Published in Antimicrob Agents Chemother on April 28, 2008
Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol (2010) 1.51
Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment. Eur J Clin Microbiol Infect Dis (2013) 1.34
Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol (2012) 1.20
The challenge of managing fusariosis. Virulence (2011) 1.10
Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study. J Clin Microbiol (2011) 1.01
Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore) (2011) 0.97
Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus. J Clin Microbiol (2014) 0.96
Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility. J Clin Microbiol (2009) 0.96
Molecular phylogenetic diversity of dermatologic and other human pathogenic fusarial isolates from hospitals in northern and central Italy. J Clin Microbiol (2010) 0.95
European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis (2014) 0.92
Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host. Fungal Biol (2011) 0.89
Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes. Cornea (2013) 0.87
Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology. Eur J Clin Microbiol Infect Dis (2011) 0.86
Last generation triazoles for imported eumycetoma in eleven consecutive adults. PLoS Negl Trop Dis (2014) 0.85
Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections. Drug Des Devel Ther (2010) 0.82
Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes. Clin Ophthalmol (2013) 0.81
Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience. Open Forum Infect Dis (2015) 0.81
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum. Antimicrob Agents Chemother (2009) 0.79
Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests. Springerplus (2014) 0.78
Comparative Evaluation of Etest, EUCAST and CLSI Methods for Amphotericin B, Voriconazole and Posaconazole against Clinically Relevant Fusarium Species. Antimicrob Agents Chemother (2016) 0.75
Fusarium incarnatum/equiseti hemodialysis graft infection. Infect Dis Rep (2010) 0.75
Skin nodules in a patient with acute lymphoblastic leukaemia. BMJ Case Rep (2014) 0.75
Fusarium Keratitis in Germany. J Clin Microbiol (2017) 0.75
Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies. Proc Natl Acad Sci U S A (1998) 6.46
Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis (2003) 3.70
Fusarium infections in immunocompromised patients. Clin Microbiol Rev (2007) 3.44
Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis (2006) 2.45
Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis (2002) 2.44
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol (1999) 2.11
In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob Agents Chemother (2002) 1.52
Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother (2007) 1.31
Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol (2005) 1.28
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis (2005) 1.11
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol (2005) 3.18
Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol (2009) 2.80
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis (2008) 2.55
Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEMS Yeast Res (2006) 1.43
Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol (2012) 1.20
Uneven distribution of mating types among genotypes of Candida glabrata isolates from clinical samples. Eukaryot Cell (2009) 1.20
The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood. J Antimicrob Chemother (2003) 1.16
Legionella infection risk from domestic hot water. Emerg Infect Dis (2004) 1.15
Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). Mycoses (2011) 1.11
In vitro activity of conventional antifungal drugs and natural essences against the yeast-like alga Prototheca. J Antimicrob Chemother (2008) 1.03
Cryptococcus neoformans population includes hybrid strains homozygous at mating-type locus. FEMS Yeast Res (2006) 1.01
The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production. J Antimicrob Chemother (2005) 0.95
Cryptococcus gattii serotype-C strains isolated in Bangalore, Karnataka, India. Mycoses (2011) 0.93
Retrospective study of onychomycosis in Italy: 1985-2000. Mycoses (2005) 0.91
Four-year persistence of a single Candida albicans genotype causing bloodstream infections in a surgical ward proven by multilocus sequence typing. J Clin Microbiol (2006) 0.89
Factors contributing to epidemic MRSA clones replacement in a hospital setting. PLoS One (2012) 0.89
Molecular epidemiology of Italian clinical Cryptococcus neoformans var. grubii isolates. Med Mycol (2013) 0.88
In vitro testing of fungicidal activity of biocides against Aspergillus fumigatus. J Med Microbiol (2005) 0.86
Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology (2008) 0.84
Global population structure of Aspergillus terreus inferred by ISSR typing reveals geographical subclustering. BMC Microbiol (2011) 0.82
Relationship between mineral content of domestic hot water and microbial contamination. J Trace Elem Med Biol (2003) 0.80
Antifungal susceptibility profiles of Candida isolates from a prospective survey of invasive fungal infections in Italian intensive care units. J Med Microbiol (2011) 0.80
Emerging imported parasitoses in Italy. Eur J Dermatol (2004) 0.79
Allergic fungal rhinosinusitis due to Curvularia lunata. New Microbiol (2014) 0.78
Tinea pedis resulting from Fusarium spp. Int J Dermatol (2002) 0.78
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis. J Med Microbiol (2005) 0.77
Comparison of effects of human serum and horse serum on in vitro susceptibility testing of echinocandins. J Chemother (2013) 0.76
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy. J Antimicrob Chemother (2006) 0.76
Cryptococcus neoformans typing by PCR fingerprinting using (GACA)4 primers based on C. neoformans genome project data. J Clin Microbiol (2007) 0.75
Welcome address. J Chemother (2007) 0.75
Fatal vancomycin- and linezolid-resistant Enterococcus faecium sepsis in a child undergoing allogeneic haematopoietic stem cell transplantation for beta-thalassaemia major. J Med Microbiol (2010) 0.75
Mycetoma Caused by Aspergillus nidulans. Acta Derm Venereol (2016) 0.75
Electrophoretic karyotyping of Cryptococcus neoformans AD-hybrid strains. Mycoses (2008) 0.75
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis (2006) 0.75
Biofilm production by Candida isolates from a survey of invasive fungal infections in Italian intensive care units. J Chemother (2012) 0.75